These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2651533)

  • 41. Shiga toxin induces medullary tubular injury in isolated perfused rat kidneys.
    Shibolet O; Shina A; Rosen S; Cleary TG; Brezis M; Ashkenazi S
    FEMS Immunol Med Microbiol; 1997 May; 18(1):55-60. PubMed ID: 9215587
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Shiga-like cytotoxin production by enteropathogenic Escherichia coli serogroups.
    Cleary TG; Mathewson JJ; Faris E; Pickering LK
    Infect Immun; 1985 Jan; 47(1):335-7. PubMed ID: 3880727
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pathogenesis of Shigella diarrhea. IX. Simplified high yield purification of Shigella toxin and characterization of subunit composition and function by the use of subunit-specific monoclonal and polyclonal antibodies.
    Donohue-Rolfe A; Keusch GT; Edson C; Thorley-Lawson D; Jacewicz M
    J Exp Med; 1984 Dec; 160(6):1767-81. PubMed ID: 6392471
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structure-function analyses of Shiga toxin and the Shiga-like toxins.
    Jackson MP
    Microb Pathog; 1990 Apr; 8(4):235-42. PubMed ID: 2200941
    [No Abstract]   [Full Text] [Related]  

  • 45. Cloning and sequencing of the genes for Shiga toxin from Shigella dysenteriae type 1.
    Strockbine NA; Jackson MP; Sung LM; Holmes RK; O'Brien AD
    J Bacteriol; 1988 Mar; 170(3):1116-22. PubMed ID: 2830229
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Shiga toxin: purification, structure, and function.
    Donohue-Rolfe A; Acheson DW; Keusch GT
    Rev Infect Dis; 1991; 13 Suppl 4():S293-7. PubMed ID: 2047652
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interaction of Shigella shigae cytotoxin with receptors on sensitive and insensitive cells.
    Eiklid K; Olsnes S
    J Recept Res; 1980; 1(2):199-213. PubMed ID: 6895387
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Secretory immunoglobulin A response to Shiga toxin in rabbits: kinetics of the initial mucosal immune response and inhibition of toxicity in vitro and in vivo.
    Keren DF; Brown JE; McDonald RA; Wassef JS
    Infect Immun; 1989 Jul; 57(7):1885-9. PubMed ID: 2659525
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Purification of Shiga toxin by alpha-D-galactose-(1----4)-beta-D-galactose-(1----4)-beta-D-glucose-(1- ---) receptor ligand-based chromatography.
    Ryd M; Alfredsson H; Blomberg L; Andersson A; Lindberg AA
    FEBS Lett; 1989 Dec; 258(2):320-2. PubMed ID: 2689221
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ionic requirements for entry of Shiga toxin from Shigella dysenteriae 1 into cells.
    Sandvig K; Brown JE
    Infect Immun; 1987 Feb; 55(2):298-303. PubMed ID: 3542829
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A method for detecting Shiga toxin and Shiga-like toxin-I in pure and mixed culture.
    Ashkenazi S; Cleary TG
    J Med Microbiol; 1990 Aug; 32(4):255-61. PubMed ID: 2391709
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of Shiga-like toxin in Escherichia coli strains, etiological agents of diarrheal disease.
    Meitert T; Tonciu M; Ciudin L; Pencu E; Mihai I; Nicolescu S
    Arch Roum Pathol Exp Microbiol; 1989; 48(4):293-8. PubMed ID: 2520669
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular probe analysis of Shigella dysenteriae type 1 isolates from 1940 to 1987.
    Blaser MJ; Miotto K; Hopkins JA
    Int J Epidemiol; 1992 Jun; 21(3):594-8. PubMed ID: 1353066
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathogenesis of Shigella diarrhea. VII. Evidence for a cell membrane toxin receptor involving beta1 leads to 4-linked N-acetyl-D-glucosamine oligomers.
    Keusch GT; Jacewicz M
    J Exp Med; 1977 Aug; 146(2):535-46. PubMed ID: 327017
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The rediscovery of Shiga toxin and its role in clinical disease.
    Keusch GT
    Jpn J Med Sci Biol; 1998; 51 Suppl():S5-22. PubMed ID: 10211432
    [No Abstract]   [Full Text] [Related]  

  • 56. Human microvascular endothelial cells are strongly sensitive to Shiga toxins.
    Ohmi K; Kiyokawa N; Takeda T; Fujimoto J
    Biochem Biophys Res Commun; 1998 Oct; 251(1):137-41. PubMed ID: 9790920
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Shiga and Shiga-like toxins].
    Ciudin L
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1990; 35(1):1-16. PubMed ID: 2173117
    [No Abstract]   [Full Text] [Related]  

  • 58. Towards a vaccine candidate against Shigella dysenteriae 1: expression of the Shiga toxin B-subunit in an attenuated Shigella flexneri aroD carrier strain.
    Tzschaschel BD; Klee SR; de Lorenzo V; Timmis KN; Guzmán CA
    Microb Pathog; 1996 Oct; 21(4):277-88. PubMed ID: 8905616
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of the effects of Shiga-like toxin 1 on cytokine- and butyrate-treated human umbilical and saphenous vein endothelial cells.
    Keusch GT; Acheson DW; Aaldering L; Erban J; Jacewicz MS
    J Infect Dis; 1996 May; 173(5):1164-70. PubMed ID: 8627068
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structure of the shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3.
    Ling H; Boodhoo A; Hazes B; Cummings MD; Armstrong GD; Brunton JL; Read RJ
    Biochemistry; 1998 Feb; 37(7):1777-88. PubMed ID: 9485303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.